A single catalyst, like a master key, can now unlock two different kinds of molecular building blocks — a trick chemists in South Korea say could change how we make new medicines. In the quiet labs of Sungkyunkwan University (SKKU) in Suwon, Do Hyun Ryu's team built two new catalytic tools that snap complex molecules together with astonishing precision.
Here's why it matters. Many of our most powerful medicines and natural products are built from carbon atoms arranged in elaborate three-dimensional shapes. Get even one atom pointing the wrong way and the whole molecule may stop working — or start causing harm. For decades, chemists have struggled to control exactly where a reaction happens and how atoms are arranged in space, all at the same time. That challenge has been one of the great bottlenecks of organic synthesis.
Ryu's team engineered a solution. In their first study, done with Hyunwoo Kim's group at the Korea Advanced Institute of Science and Technology (KAIST), they showed that one chiral organic catalyst can drive two different carbon-carbon bond-forming reactions with high selectivity. A chiral catalyst is a molecular helper that prefers one "handed" version of a molecule over the other, much like a glove that only fits one hand. The same catalyst controlled both an allylation reaction and an aldol reaction — two reactions that had each been tricky to manage on their own. It picked the right reaction site and shaped the final molecule's three-dimensional structure in a single step.
The payoff was real. The team turned their products into biologically active natural products, including (+)-dimethyl citramalate, and used computer calculations called density functional theory to reveal exactly how the catalyst does its work.
The second study tackled a different puzzle: building tetrahydrofuran rings. These five-membered rings contain one oxygen atom and show up in many medicines and natural products. In the past, chemists often needed starting materials that already carried the correct stereochemical structure — a kind of head start. Ryu's team broke that rule, using a chiral organic catalyst to build multiple stereocenters straight from simple, flat starting materials. They even produced a key building block for (+)-altholactone, a natural product with anticancer activity, hinting at the method's power for drug discovery.
Both studies, published in Angewandte Chemie International Edition, share a single vision: precise control over where reactions happen and how molecules are shaped. Together, they expand what asymmetric synthesis — the art of building molecules with exact handedness — can achieve.
Ryu put it plainly: "These studies demonstrate new possibilities for building complex molecular structures more precisely and efficiently." The next steps, he says, include extending the approach to even broader reactions and crafting valuable compounds for pharmaceuticals and beyond. If a single catalyst can master two reactions at once, the future of molecule-making just got a little more hopeful.